NL-OMON38294尚未招募不适用
Response to vaccination in lymphoma patients treated with CHOP and rituximab. - RITUXIVAC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patients with non-Hodgkin*s lymphoma, treated with rituximab (with a range of 6-12 cycles) and who are in remission.
- •2. Completion of rituximab therapy in the last twelve months before start of the study.
- •3. Age >= 18 years.
- •4. Signing of informed consent.;Controls:
- •1. Age, sex and co-morbidity matched controls
排除标准
- •1. Completion of rituximab therapy 7-8 months before start of the study.
- •2. Fever at time of vaccination.
- •3. Previous/known allergic reaction to any of the components of the vaccines given.;Controls:
- •1. Immunocompromised persons will be excluded (for example immunosuppressive medication).
研究者
相似试验
撤回
不适用
Vaccination response in lymphoma patients treated with CHOP and rituximabB-cell malignancylymph node cancer1002532010004018NL-OMON32777Sint Antonius Ziekenhuis140
进行中（未招募）
不适用
Reponse to vaccination in patients with bonemarrowcancer who are treated with chemotherapy.multiple myelomaEUCTR2012-005713-39-NLSt. Antonius Hospital
已完成
2 期
Vaccination with recombinant lymphoma idiotype in indolent lymphoma in advanced stagesIndolent B cell lymphomaC82C83.0C83.1Small cell B-cell lymphomaFollicular lymphomaMantle cell lymphomaDRKS00000227Abteilung Innere Medizin IUniversitätsklinikum Freiburg42
已完成
1 期
Vaccination of cancer patients for preventing cancer developmentymphoma.B-cell lymphoma, unspecifiedIRCT138712071715N1Mazandaran University of Medical Sciences10
尚未招募
不适用
Efficienty of vaccination in patients with cancer who are treated with chemotherapy.lymphoma, non-hodgkins lymphoma, NHL, vaccination, influenza, humoral response, rituximab.lymfoom, non-hodgekin's lymfoma, NHL, vaccinatie, influenza, humorale respons, rituximab.NL-OMON23415St. Antonius Ziekenhuis Nieuwegein160